Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in ZYME — Zymeworks Inc.

CIK 1167557 Greenwich, CT
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,908,908
+$638,560 QoQ
Shares Held
111,282
+22.7% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 202 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. ZYME ranks #106 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in ZYME

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,908,908 111,282
2026-03-31 $2,270,348 90,669
2025-12-31 $2,398,002 91,075
2025-09-30 $2,606,952 152,632
2025-06-30 $2,085,091 166,143
2025-03-31 $577,455 48,485
2024-12-31 $381,721 26,074
2024-09-30 $312,017 24,862
2024-06-30 $802,254 94,272
2024-03-31 $5,149,560 489,502
2023-12-31 $7,129,513 686,190
2023-09-30 $5,069,964 799,679
2023-06-30 $4,056,186 469,466